➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Harvard Business School
Boehringer Ingelheim

Last Updated: August 5, 2021

DrugPatentWatch Database Preview

Drugs in Development Information for Squalamine

Email this page to a colleague

« Back to Dashboard

What is the development status for investigational drug Squalamine?

Squalamine is an investigational drug.

There have been 12 clinical trials for Squalamine. The most recent clinical trial was a Phase 2 trial, which was initiated on June 1st 2005.

The most common disease conditions in clinical trials are Macular Degeneration, Macular Edema, and Choroidal Neovascularization. The leading clinical trial sponsors are Ohr Pharmaceutical Inc., Genaera Corporation, and National Cancer Institute (NCI).

Recent Clinical Trials for Squalamine
Efficacy and Safety Study of Squalamine Ophthalmic Solution in Subjects With Neovascular AMDOhr Pharmaceutical Inc.Phase 3
Effect of Squalamine Lactate Ophthalmic Solution, 0.2% in Subjects With Neovascular Age-Related Macular DegenerationOhr Pharmaceutical Inc.Phase 2
Squalamine Lactate Eye Drops in Combination With Ranibizumab in Patients With Diabetic Macular Edema (DME)Ohr Pharmaceutical Inc.Phase 2

See all Squalamine clinical trials

Clinical Trial Summary for Squalamine

Top disease conditions for Squalamine
Top clinical trial sponsors for Squalamine

See all Squalamine clinical trials

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.